Houman D. Hemmati
Directeur/Membre du Conseil chez Mediprint Ophthalmics, Inc.
Profil
Houman D.
Hemmati is currently a Director at Noveome Biotherapeutics, Inc. and also holds Director positions at Trailhead Biosystems, Inc. and Mediprint Ophthalmics, Inc. Previously, he was an Advisor at Draper Fisher Jurvetson ePlanet Ventures, a Research Analyst at Griffen-Rose LLC, and a Vice President-Medical & Clinical Development at Capricor Therapeutics, Inc. Hemmati received his undergraduate degree from Stanford University and his doctorate degrees from the University of California, Los Angeles and the California Institute of Technology.
Postes actifs de Houman D. Hemmati
| Sociétés | Poste | Début |
|---|---|---|
Mediprint Ophthalmics, Inc.
 Mediprint Ophthalmics, Inc. Packaged SoftwareTechnology Services Mediprint Ophthalmics, Inc. engages in the development of contact lenses technologies that treats eye diseases. The company was founded by Kokila Doshi and Praful Doshi and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | - |
Trailhead Biosystems, Inc.
 Trailhead Biosystems, Inc. Medical SpecialtiesHealth Technology Trailhead Biosystems, Inc. develops cell therapies. Its program includes cancer immunotherapy, bone induction, neural fate space project, kidney and blood program. The company was founded by Jan Jensen in 2013 and is headquartered in Cleveland, OH. | Directeur/Membre du Conseil | - |
Noveome Biotherapeutics, Inc.
 Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Noveome Biotherapeutics, Inc. develops novel biotherapeutic products that restore cell communication and system homeostasis. Its proprietary technology platform, derived from human placental cells, provides an exciting new approach to tissue regeneration and repair in a wide range of medical conditions and offers hope, especially in patients with maladies. The company was founded in 2001 by George L. Sing and William J. Golden and is headquartered in Pittsburgh, PA. | Directeur/Membre du Conseil | 16/11/2022 |
Anciens postes connus de Houman D. Hemmati
| Sociétés | Poste | Fin |
|---|---|---|
Draper Fisher Jurvetson ePlanet Ventures
 Draper Fisher Jurvetson ePlanet Ventures Investment ManagersFinance Founded in 1999, Draper Fisher Jurvetson ePlanet Ventures (DFJ ePlanet), founded by Asad Jamal, in partnership with Draper Fisher Jurvetson is a global venture capital firm headquartered in Redwood City, California with additional offices in Singapore, Beijing, Shanghai, Hong Kong London Tokyo and Mumbai. | Corporate Officer/Principal | - |
| CAPRICOR THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Griffen-Rose LLC
 Griffen-Rose LLC Investment ManagersFinance Founded in 2003, Griffen-Rose LLC is an independent research firm located in New York City. Griffen serves the small- and micro-cap sectors by producing research reports to institutional investors. They focus on companies in a broad range of sectors including: alternative/renewable energy technology, beverages, biotechnology and drug discovery, coal production/mining, consumer goods, financial services, industrial raw materials and infrastructural goods, infrastructure construction, industrial heavy machinery, metals production/mining, power generation/utilities and real estate. | Analyst-Equity | - |
Formation de Houman D. Hemmati
| Stanford University | Undergraduate Degree |
| University of California, Los Angeles | Doctorate Degree |
| California Institute of Technology | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CAPRICOR THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Draper Fisher Jurvetson ePlanet Ventures
Draper Fisher Jurvetson ePlanet Ventures Investment ManagersFinance Founded in 1999, Draper Fisher Jurvetson ePlanet Ventures (DFJ ePlanet), founded by Asad Jamal, in partnership with Draper Fisher Jurvetson is a global venture capital firm headquartered in Redwood City, California with additional offices in Singapore, Beijing, Shanghai, Hong Kong London Tokyo and Mumbai. | Finance |
Griffen-Rose LLC
Griffen-Rose LLC Investment ManagersFinance Founded in 2003, Griffen-Rose LLC is an independent research firm located in New York City. Griffen serves the small- and micro-cap sectors by producing research reports to institutional investors. They focus on companies in a broad range of sectors including: alternative/renewable energy technology, beverages, biotechnology and drug discovery, coal production/mining, consumer goods, financial services, industrial raw materials and infrastructural goods, infrastructure construction, industrial heavy machinery, metals production/mining, power generation/utilities and real estate. | Finance |
Noveome Biotherapeutics, Inc.
Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Noveome Biotherapeutics, Inc. develops novel biotherapeutic products that restore cell communication and system homeostasis. Its proprietary technology platform, derived from human placental cells, provides an exciting new approach to tissue regeneration and repair in a wide range of medical conditions and offers hope, especially in patients with maladies. The company was founded in 2001 by George L. Sing and William J. Golden and is headquartered in Pittsburgh, PA. | Health Technology |
Trailhead Biosystems, Inc.
Trailhead Biosystems, Inc. Medical SpecialtiesHealth Technology Trailhead Biosystems, Inc. develops cell therapies. Its program includes cancer immunotherapy, bone induction, neural fate space project, kidney and blood program. The company was founded by Jan Jensen in 2013 and is headquartered in Cleveland, OH. | Health Technology |
Mediprint Ophthalmics, Inc.
Mediprint Ophthalmics, Inc. Packaged SoftwareTechnology Services Mediprint Ophthalmics, Inc. engages in the development of contact lenses technologies that treats eye diseases. The company was founded by Kokila Doshi and Praful Doshi and is headquartered in San Diego, CA. | Technology Services |
